PPA
FOLD

Parametric Portfolio Associates’s Amicus Therapeutics FOLD Stock Holding History

Parametric Portfolio Associates’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.34M Sell
141,326
-169,771
-55% -$1.59M ﹤0.01% 2640
2021
Q4 		$3.59M Buy
311,097
+7,687
+3% +$85.7K ﹤0.01% 2087
2021
Q3 		$2.9M Sell
303,410
-15,991
-5% -$164K ﹤0.01% 2185
2021
Q2 		$3.08M Buy
319,401
+27,272
+9% +$266K ﹤0.01% 2174
2021
Q1 		$2.89M Sell
292,129
-59,420
-17% -$920K ﹤0.01% 2546
2020
Q4 		$8.12M Buy
351,549
+118,523
+51% +$2.42M 0.01% 1737
2020
Q3 		$3.29M Buy
233,026
+18,459
+9% +$269K ﹤0.01% 2181
2020
Q2 		$3.24M Buy
214,567
+21,768
+11% +$265K ﹤0.01% 2190
2020
Q1 		$1.78M Buy
192,799
+29,880
+18% +$284K ﹤0.01% 2456
2019
Q4 		$1.59M Buy
162,919
+67,204
+70% +$615K ﹤0.01% 2830
2019
Q3 		$768K Buy
95,715
+24,048
+34% +$261K ﹤0.01% 3161
2019
Q2 		$894K Sell
71,667
-17,144
-19% -$218K ﹤0.01% 3101
2019
Q1 		$1.21M Buy
88,811
+710
+0.8% +$8.67K ﹤0.01% 2931
2018
Q4 		$844K Buy
88,101
+7,856
+10% +$86.4K ﹤0.01% 3073
2018
Q3 		$970K Sell
80,245
-11,576
-13% -$162K ﹤0.01% 3115
2018
Q2 		$1.43M Buy
91,821
+5,291
+6% +$80K ﹤0.01% 2867
2018
Q1 		$1.3M Buy
86,530
+10,341
+14% +$157K ﹤0.01% 2875
2017
Q4 		$1.1M Buy
76,189
+3,266
+4% +$44.9K ﹤0.01% 2977
2017
Q3 		$1.1M Buy
72,923
+44,924
+160% +$594K ﹤0.01% 2984
2017
Q2 		$282K Buy
+27,999
New +$225K ﹤0.01% 3660
2017
Q1 		– Sell
-40,245
Closed -$200K – 3789
2016
Q4 		$200K Sell
40,245
-12,958
-24% -$89.7K ﹤0.01% 3595
2016
Q3 		$394K Buy
+53,203
New +$359K ﹤0.01% 3286
2016
Q2 		– Sell
-177,701
Closed -$1.5M – 3866
2016
Q1 		$1.5M Buy
177,701
+128,025
+258% +$907K ﹤0.01% 2619
2015
Q4 		$482K Buy
49,676
+11,844
+31% +$107K ﹤0.01% 3278
2015
Q3 		$529K Buy
37,832
+5,313
+16% +$83.3K ﹤0.01% 2693
2015
Q2 		$460K Buy
+32,519
New +$391K ﹤0.01% 3332
2014
Q2 		– Sell
-12,813
Closed -$27K – 3754
2014
Q1 		$27K Buy
12,813
+111
+0.9% +$278 ﹤0.01% 3804
2013
Q4 		$30K Buy
+12,702
New +$27.9K ﹤0.01% 3801

Other funds holding FOLD

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parametric Portfolio Associates's FOLD Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Amicus Therapeutics (FOLD) stake by 55% in Q1 2022, selling an estimated $1.59M and leaving 141,326 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

Parametric Portfolio Associates first reported a position in FOLD in Q4 2013 and has held it in 28 quarters since. The position peaked at $8.12M in Q4 2020. 217 funds tracked by Wall St. Rank hold FOLD as of Q1 2022.

  • Parametric Portfolio Associates held 141,326 shares of Amicus Therapeutics worth $1.34M as of Q1 2022.
  • Parametric Portfolio Associates sold 169,771 Amicus Therapeutics shares in Q1 2022, an estimated $1.59M.
  • Amicus Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2640 holding.
  • Parametric Portfolio Associates first reported a position in Amicus Therapeutics in Q4 2013 and has held it in 28 quarters since.
  • Parametric Portfolio Associates's Amicus Therapeutics position peaked at $8.12M in Q4 2020.
  • 217 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.